Zylox-Tonbridge Medical Technology Co., Ltd.

Informe acción SEHK:2190

Capitalización de mercado: HK$3.5b

Zylox-Tonbridge Medical Technology Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jonathon Zhao

Chief Executive Officer (CEO)

CN¥17.4m

Compensación total

Porcentaje del salario del CEO17.3%
Permanencia del CEO12yrs
Participación del CEO12.9%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva3.7yrs

Actualizaciones recientes de la dirección

Recent updates

Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Oct 02
Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher

Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Sep 27
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business

Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Apr 23
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon

Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Jan 18
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate

Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

Sep 21
Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?

There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

Aug 03
There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jun 30
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

Mar 08
Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?

We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Jan 19
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate

Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Jul 06
Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely

Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Oct 05
Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jonathon Zhao en comparación con los beneficios de Zylox-Tonbridge Medical Technology?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

CN¥26m

Mar 31 2024n/an/a

-CN¥27m

Dec 31 2023CN¥17mCN¥3m

-CN¥79m

Sep 30 2023n/an/a

-CN¥101m

Jun 30 2023n/an/a

-CN¥124m

Mar 31 2023n/an/a

-CN¥119m

Dec 31 2022CN¥21mCN¥3m

-CN¥114m

Sep 30 2022n/an/a

-CN¥135m

Jun 30 2022n/an/a

-CN¥155m

Mar 31 2022n/an/a

-CN¥178m

Dec 31 2021CN¥16mCN¥2m

-CN¥200m

Sep 30 2021n/an/a

-CN¥168m

Jun 30 2021n/an/a

-CN¥135m

Mar 31 2021n/an/a

-CN¥118m

Dec 31 2020CN¥10mCN¥1m

-CN¥100m

Dec 31 2019CN¥1mCN¥746k

-CN¥67m

Compensación vs. Mercado: La compensación total de Jonathon($USD2.40M) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD390.12K).

Compensación vs. Ingresos: La compensación de Jonathon ha sido consistente con los resultados de la empresa en el último año.


CEO

Jonathon Zhao (57 yo)

12yrs

Permanencia

CN¥17,389,000

Compensación

Dr. Zhong Zhao also known as Jonathon, serves as Director of Avinger, Inc. since March 04, 2024. He is Founder of Zylox-Tonbridge Medical Technology Co., Ltd. and serves as its Chairman since November 06,...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Zhong Zhao
Founder12yrsCN¥17.39m12.95%
HK$ 458.6m
Yang Xie
Senior VP of Sales & Marketing and Executive Director6.7yrsCN¥10.53m0.12%
HK$ 4.4m
Zheng Li
Senior VP5.8yrsCN¥8.37m1.58%
HK$ 56.1m
Yun Qiu
Independent Non-Executive Director3.7yrsCN¥200.00ksin datos
Hui Wang
Non-Executive Director3.9yrssin datossin datos
Dasong Wang
Non-Executive Director4.1yrssin datossin datos
Dongfang Li
Non Executive Director2.5yrssin datossin datos
Jian Ji
Independent Non-Executive Director3.7yrsCN¥200.00ksin datos
Hongbo Wang
Employee Supervisor3.7yrssin datossin datos
Tao Liu
Supervisor2.5yrssin datossin datos
Chang'an Ma
Chairman of the Board of Supervisorsless than a yearsin datossin datos
Xiang Qian
Independent Non-Executive Directorless than a yearsin datossin datos

3.7yrs

Permanencia media

51yo

Promedio de edad

Junta con experiencia: La junta directiva de 2190 se considera experimentada (3.7 años de antigüedad promedio).